Patents by Inventor Ji-Hyung Chung
Ji-Hyung Chung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240153792Abstract: An apparatus and method for processing a substrate can reduce the concentration of process by-products in a chemical solution.Type: ApplicationFiled: November 7, 2023Publication date: May 9, 2024Applicants: SEMES CO., LTD., SAMSUNG ELECTRONICS CO., LTD.Inventors: Min Jung KIM, Jin Ah HAN, Hee Hwan KIM, Yong Hoon HONG, Kyoung Suk KIM, Jong Hyeok PARK, Jin Hyung PARK, Dae Hyuk CHUNG, Ji Hoon CHA
-
Patent number: 11945744Abstract: Disclosed are a method and apparatus for reusing wastewater. The method for reusing wastewater disclosed herein includes: generating a mixed wastewater by mixing multiple types of wastewater (S20); performing a first purification by passing the mixed wastewater through a flocculation-sedimentation unit (S40); performing a second purification by passing an effluent of the flocculation-sedimentation unit through a membrane bioreactor (MBR) (S60); performing a third purification by passing an effluent of the MBR through a reverse-osmosis membrane unit (S80); and reusing an effluent of the reverse-osmosis membrane unit as cooling water or industrial water (S100).Type: GrantFiled: April 14, 2023Date of Patent: April 2, 2024Assignees: SAMSUNG ENGINEERING CO., LTD., SAMSUNG ELECTRONICS CO., LTDInventors: Seok Hwan Hong, Dae Soo Park, Seung Joon Chung, Yong Xun Jin, Jae Hyung Park, Jae Hoon Choi, Jae Dong Hwang, Jong Keun Yi, Su Hyoung Cho, Kyu Won Hwang, June Yurl Hur, Je Hun Kim, Ji Won Chun
-
Publication number: 20220023393Abstract: The present invention relates to a composition for preventing or treating obesity or sarcopenia, containing ATPase inhibitory factor 1 (IF1) and, more specifically, to a pharmaceutical composition and a food for preventing or treating obesity or sarcopenia, containing, as an active ingredient, IF1 having an effect of suppressed appetite or effects increased muscle mass and muscle production. According to the present invention, ATPase inhibitory factor 1 (IF1) exhibits, in an obesity-induced mouse model, effects of inhibited weight gain and decreased dietary intake without side effects, and exhibits, in obesity-induced or aged mouse, effects of increased muscle mass, increased muscle protein and muscle production, and thus is very useful as an agent for preventing, alleviating or treating metabolic diseases such as obesity, an agent for suppressing appetite and an agent for preventing, alleviating or treating muscle loss-related diseases such as sarcopenia.Type: ApplicationFiled: September 11, 2019Publication date: January 27, 2022Applicants: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Min-Jeong SHIN, Hyeon Soo KIM, Ji Hyung CHUNG
-
Publication number: 20210386822Abstract: The present invention pertains to an anticancer composition containing IF1 (ATPase inhibitory factor 1). The IF1 (ATPase inhibitory factor 1) according to the present invention has the effect of releasing extracellular ATP, induces cytotoxicity in various cancer cells and exhibits anticancer efficacy, and is thus very useful as an active ingredient of a powerful anticancer agent.Type: ApplicationFiled: October 2, 2019Publication date: December 16, 2021Applicants: Korea University Research And Business Foundation, CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Min-Jeong SHIN, Hyeon Soo KIM, Inhyeok JEONG, Eun Hye YOO, Ji Hyung CHUNG
-
Patent number: 10987295Abstract: Provided is a novel peptide and a cosmetic composition for inhibiting a skin-aging or a skin-wrinkle formation including the same. The peptide has activities for facilitating the bindings between keratinocytes; and increasing the expressions of junction proteins significantly.Type: GrantFiled: June 23, 2020Date of Patent: April 27, 2021Assignee: College of Medicine Pochon CHA University Industry-Academic Cooperation FoundationInventors: Ji-Hyung Chung, Da-Yoon Chung
-
Publication number: 20200315941Abstract: Provided is a novel peptide and a cosmetic composition for inhibiting a skin-aging or a skin-wrinkle formation including the same. The peptide has activities for facilitating the bindings between keratinocytes; and increasing the expressions of junction proteins significantly.Type: ApplicationFiled: June 23, 2020Publication date: October 8, 2020Applicant: College of Medicine Pochon CHA University Industry-Academic Cooperation FoundationInventors: Ji-Hyung CHUNG, Da-Yoon CHUNG
-
Patent number: 10729635Abstract: Provided is a novel peptide and a cosmetic composition for inhibiting a skin-aging or a skin-wrinkle formation including the same. The peptide has activities for facilitating the bindings between keratinocytes; and increasing the expressions of junction proteins significantly.Type: GrantFiled: October 30, 2017Date of Patent: August 4, 2020Assignee: College of Medicine Pochon CHA University-Industry-Academic Cooperation FoundationInventors: Ji-Hyung Chung, Da-Yoon Chung
-
Peptide and cosmetic composition comprising same for preventing skin aging or skin wrinkle formation
Patent number: 10478392Abstract: Provided herein is a peptide, a cosmetic composition comprising the same, and a method for inhibiting skin-aging or skin-wrinkle formation using the same, the peptide having activities for facilitating the bindings between keratinocytes; and increasing the expressions of junction proteins.Type: GrantFiled: October 27, 2016Date of Patent: November 19, 2019Assignee: College of Medicine Pochon CHA University Industry-Academic Cooperation FoundationInventor: Ji-Hyung Chung -
Publication number: 20190274942Abstract: Provided is a novel peptide and a cosmetic composition for inhibiting a skin-aging or a skin-wrinkle formation including the same. The peptide has activities for facilitating the bindings between keratinocytes; and increasing the expressions of junction proteins significantly.Type: ApplicationFiled: October 30, 2017Publication date: September 12, 2019Applicant: College of Medicine Pochon CHA University Industry-Academic Cooperation FoundationInventors: Ji-Hyung CHUNG, Da-Yoon CHUNG
-
Publication number: 20180325794Abstract: Provided herein is a peptide, a cosmetic composition comprising the same, and a method for inhibiting skin-aging or skin-wrinkle formation using the same, the peptide having activities for facilitating the bindings between keratinocytes; and increasing the expressions of junction proteins.Type: ApplicationFiled: October 27, 2016Publication date: November 15, 2018Applicant: College of Medicine Pochon CHA University Industry -Academic Cooperation FoundationInventor: Ji-Hyung CHUNG
-
Patent number: 9110059Abstract: A bio-pin is provided. The bio-pin can be used for cell transfer and treatment, cell tracing, and targeting of specific tissues and cells using a peptide-based complex in which a cell-penetrating peptide or a cell-adhesive peptide is bound to one or both ends of a cell membrane protein, and used in a molecular imaging system, a medical appliance, and the like.Type: GrantFiled: March 15, 2012Date of Patent: August 18, 2015Assignee: Industry-Academic Cooperation Foundation, Yonsei UniversityInventors: Ji Hyung Chung, Yang Soo Jang
-
Publication number: 20140256034Abstract: A bio-pin is provided. The bio-pin can be used for cell transfer and treatment, cell tracing, and targeting of specific tissues and cells using a peptide-based complex in which a cell-penetrating peptide or a cell-adhesive peptide is bound to one or both ends of a cell membrane protein, and used in a molecular imaging system, a medical appliance, and the like.Type: ApplicationFiled: March 15, 2012Publication date: September 11, 2014Applicant: Industry Academic Cooperation Foundation, Yonsei UniversityInventors: Ji Hyung Chung, Yang Soo Jang
-
Patent number: 7994148Abstract: The present invention relates to a transmembrane delivery peptide derived from human in which a target protein may be easily delivered into cells, and a recombinant vector comprising a nucleic acid coding the peptide. More specifically, the present invention relates to the transmembrane delivery peptide having an amino acid sequence described in SEQ ID No. 1 including 11 amino acids of specific sites in amino acid sequences of human G protein alpha 12, and a recombinant vector comprising a nucleic acid coding the same, a transformant prepared by introducing said recombinant vector, and the like. Since transmembrane delivery peptides of the present invention can be efficiently delivered into cells, they may be usefully used for the purposes of delivering various target materials, including proteins, nucleic acid, drugs and the like.Type: GrantFiled: August 2, 2007Date of Patent: August 9, 2011Assignee: Industry-Academic Cooperation Foundation, Yonsei UniversityInventors: Ji-Hyung Chung, Yang-Soo Jang
-
Publication number: 20090269842Abstract: The present invention relates to a transmembrane delivery peptide derived from human in which a target protein may be easily delivered into cells, and a recombinant vector comprising a nucleic acid coding the peptide. More specifically, the present invention relates to the transmembrane delivery peptide having an amino acid sequence described in SEQ ID No. 1 including 11 amino acids of specific sites in amino acid sequences of human G protein alpha 12, and a recombinant vector comprising a nucleic acid coding the same, a transformant prepared by introducing said recombinant vector, and the like. Since transmembrane delivery peptides of the present invention can be efficiently delivered into cells, they may be usefully used for the purposes of delivering various target materials, including proteins, nucleic acid, drugs and the like.Type: ApplicationFiled: August 2, 2007Publication date: October 29, 2009Inventors: Ji-Hyung Chung, Yang-Soo Jang